Beta
369970

eradication therapy in patients with immune thrombocytopenic purpura

Article

Last updated: 05 Jan 2025

Subjects

-

Tags

-

Abstract

Objective:
The aim was to determine the frequency of infection in patients with immune thrombocytopenic purpura (ITP) and to detect the effect of its eradication therapy on platelet count response in -positive patients.
Patients and methods:
stool antigen enzyme immunoassay test was done for 54 patients with ITP. -positive patients received standard triple therapy for 2 weeks. Platelet count response to eradication therapy was evaluated 2 and 3 months after the treatment.
Results:
infection was positive in 38 (70.4%) patients with ITP. Eradication of was achieved in 30 (78.9%) patients (responder group). There were statistically significant increases in platelet count (among the responder group) after eradication therapy at 2 and 3 months ( < 0.05).
Conclusion:
Eradication of infection in patients with ITP is associated with significant increase in platelet counts.

DOI

10.4103/JCMRP.JCMRP_154_19

Keywords

eradication, Immune thrombocytopenic purpura

Authors

First Name

Nabila

Last Name

Faiek

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Safinaz

Last Name

Hussein

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Reham

Last Name

Badr

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

Volume

5

Article Issue

1

Related Issue

49478

Issue Date

2020-01-01

Publish Date

2020-01-01

Page Start

32

Page End

35

Print ISSN

2357-0121

Online ISSN

2357-013X

Link

https://jcmrp.journals.ekb.eg/article_369970.html

Detail API

https://jcmrp.journals.ekb.eg/service?article_code=369970

Order

369,970

Publication Type

Journal

Publication Title

Journal of Current Medical Research and Practice

Publication Link

https://jcmrp.journals.ekb.eg/

MainTitle

eradication therapy in patients with immune thrombocytopenic purpura

Details

Type

Article

Created At

20 Dec 2024